Last reviewedSeptember 13, 2026
Published byMason Arnao
Primary-source standardJPML reports, federal court dockets and government sources
ImportantEducational information only — TortAdvisor is not a law firm

Published Sept. 1, 2026 · Mason Arnao · Primary sources: JPML · three federal MDL dockets · FDA
Hernia Mesh • Settlement Research • Updated September 2026

Hernia Mesh Settlement Amounts 2026: Bard, Covidien & Atrium

There is no single hernia mesh litigation. Three manufacturers sit in three separate MDLs at three different stages, and which device was implanted matters more to a claim’s value than almost anything about the injury.

Quick AnswerNo global hernia mesh settlement amount exists, because there is no global hernia mesh settlement. Bard’s litigation, MDL 2846, held 23,316 pending actions as of the Sept. 1, 2026 JPML report and has a settlement framework in place with no publicly disclosed total. Covidien’s MDL 3029 held 2,453 pending and produced an $88 million verdict in August 2026. Atrium’s MDL 2753 is down to 127 pending after a qualified settlement fund was approved in 2024. Identify the manufacturer first — everything else follows from it.
Primary sources onlyJPML reports, three MDL dockets and FDA device guidance
Analyst estimates labelledThe widely quoted Bard total is an estimate, and we say so
Not a case valuationTortAdvisor is a research publisher, not a law firm
Rechecked Sept. 1, 2026Verified against the JPML report published that morning

Latest Hernia Mesh Settlement Amounts and MDL Status

Anyone searching for a hernia mesh settlement amount is really asking three different questions, because the answer depends entirely on whose device was implanted.

Where things stand on Sept. 1, 2026: the Bard litigation, MDL 2846 before Judge Edmund A. Sargus Jr. in the Southern District of Ohio, held 23,316 pending actions of 25,213 filed and remains by far the largest. A settlement framework covering a substantial share of claims has been in place since late 2024, but no total has been publicly disclosed. Covidien’s MDL 3029 before Judge Patti B. Saris in Massachusetts held 2,453 pending and produced an $88 million plaintiff verdict in August 2026, without punitive damages. Atrium’s MDL 2753 before Judge Landya B. McCafferty in New Hampshire has fallen to 127 pending from 3,592 filed, following approval of a qualified settlement fund in 2024.
2016–2018
The three MDLs are created

Claims are consolidated separately by manufacturer: Atrium in New Hampshire, Bard in Ohio and later Covidien in Massachusetts. They have proceeded on independent timetables ever since.

Oct. 2024
Atrium settlement fund approved

A qualified settlement fund is approved in MDL 2753. The docket subsequently falls from thousands of pending actions to 127, which is what a resolving MDL looks like on the JPML report.

Late 2024
Bard settlement framework

A framework is reached covering a large share of the Bard claims. No aggregate figure is disclosed by the company or the court, and no per-claim matrix is published.

Aug. 4, 2026
Covidien verdict

A jury returns an $88 million verdict against Covidien in the Patterson trial, without punitive damages. It is the largest public hernia mesh outcome and is subject to post-trial and appellate proceedings.

Sept. 1, 2026
Three dockets, three stages

Bard remains enormous and largely unresolved on public terms, Covidien is actively trying cases after a major verdict, and Atrium is nearly wound down.

What FDA actually says about mesh. The FDA identifies pain, infection, hernia recurrence, adhesion, bowel obstruction and bleeding as the most common complications of hernia repair with or without mesh, and identifies mesh migration and contraction as additional mesh-specific risks. It also states that the medical literature has consistently demonstrated a reduced likelihood of recurrence with mesh. Both halves of that are relevant: complications are real, and mesh is not alleged to be useless. Our hernia mesh lawsuit guide covers the allegations in detail.
Hernia mesh claim stages — product identification, filing, fact sheet, framework, payment
How a hernia mesh claim proceeds. Identifying the manufacturer is the first and most consequential step.

Hernia Mesh Settlement Amounts: Confirmed Facts vs. Estimates

One number dominates coverage of this litigation, and it is not a disclosed figure.

What Is Confirmed

  • Bard MDL 2846 held 23,316 pending actions of 25,213 filed before Judge Edmund A. Sargus Jr.
  • Covidien MDL 3029 held 2,453 pending of 2,459 filed before Judge Patti B. Saris.
  • Atrium MDL 2753 held 127 pending of 3,592 filed before Judge Landya B. McCafferty.
  • A qualified settlement fund was approved in the Atrium litigation in October 2024.
  • A settlement framework covering a large share of Bard claims has been in place since late 2024.
  • An $88 million verdict was returned against Covidien in August 2026, without punitive damages.

What Is Not Known

  • The total value of the Bard settlement framework — no figure has been disclosed.
  • Per-claim allocation criteria for any of the three programmes.
  • What an individual claim is worth under any framework.
  • Whether the Covidien verdict survives post-trial and appellate review.
  • Whether Covidien reaches a broader resolution, and on what terms.
The billion-dollar figure attached to the Bard settlement is an analyst estimate derived from company financial filings, not a disclosed settlement total. Neither Bard nor the court has published an aggregate figure or a per-claim matrix. It is not an official settlement offer, a historical average or a prediction, and dividing it by a claim count produces a number with no standing.

Hernia Mesh Settlement Amounts by Claim Profile

No manufacturer has published a matrix, so these profiles describe relative position rather than dollar bands. They are TortAdvisor modelling, not official settlement offers, historical averages or predictions.

Illustrative Profile 1Strongest position

Multiple revision surgeries with severe complications

  • Explant surgery, sometimes more than once
  • Bowel obstruction, perforation, fistula or chronic infection
  • Permanent functional impairment or inability to return to work
  • Clear implant records identifying the device and manufacturer
  • Substantial documented medical costs and lost earnings
Illustrative Profile 2Middle position

Single revision surgery, complication resolved

  • One explant or repair procedure with recovery
  • Infection, migration or recurrence documented and treated
  • Some ongoing symptoms but no permanent disability
  • Implant records available
Illustrative Profile 3Constrained position

No revision surgery, or the device cannot be identified

  • Chronic pain managed without further surgery
  • Complications difficult to attribute to the mesh specifically
  • Implant records incomplete or the manufacturer unidentified
  • Limited documented economic loss
Ranges overlap and are not guarantees. An actual outcome may be lower than these profiles suggest, higher, or zero — a claim can fail entirely if the device cannot be identified, if the complication is attributed to the surgery rather than the mesh, or if the limitation period has run. Which manufacturer made the device can matter more than where a claim sits on this scale.
Hernia mesh settlement amounts factors — revision surgery, complication type, manufacturer and permanency
What moves a hernia mesh claim. Revision surgery is the clearest single driver.
Payment mechanics

How a hernia mesh settlement payment reaches a claimant

Frameworks exist here, so this sequence is real rather than hypothetical for many claimants. The lien step is unusually significant.

1

Claim assessed against framework criteria

Complication type, revision surgery and permanency are applied to the agreed criteria.

2

Attorney fees and case costs deducted

Contingency fee plus filing, expert and record-retrieval costs come out first.

3

Liens and reimbursements resolved

Medicare, Medicaid and private insurers recover what they paid for revision surgery.

4

Net payment issued

Because explant and revision surgery is expensive, liens can absorb a large share of a gross allocation.

No per-claim matrix has been published by any of the three manufacturers, so the criteria applied at step one are not publicly known.

How TortAdvisor Handles Hernia Mesh Settlement Amounts

The central discipline on this topic is refusing to convert a company’s financial disclosure into a settlement figure.

01

Keep the three MDLs separate

Bard, Covidien and Atrium are different defendants at different stages. A single hernia mesh average would describe none of them.

02

Label analyst estimates

A figure inferred from a company’s accounts is an estimate by a third party. It is reported as that, never as a disclosed settlement total.

03

Distinguish verdicts from settlements

The $88 million Covidien verdict is a jury award subject to appeal, not a benchmark for what settling claims receive.

04

Track the current docket

Case counts come from the current month’s JPML report. A collapsing pending count, as in the Atrium docket, is itself informative.

Editorial methodology: TortAdvisor separates confirmed facts from estimates and avoids describing projections as settlements. See how TortAdvisor compiles settlement and verdict estimates.
How a hernia mesh settlement payment reaches a claimant — allocation, fees, liens, net
Surgical liens are unusually large in mesh claims, which is why gross and net diverge sharply.

The Three Hernia Mesh MDLs Compared

Identifying the manufacturer is the first question in any hernia mesh claim, because it determines everything that follows.

Manufacturer MDL, court and judge Pending / filed Resolution status
Bard (Becton Dickinson) MDL 2846, S.D. Ohio, Judge Edmund A. Sargus Jr. 23,316 / 25,213 Settlement framework in place since late 2024, no total or matrix disclosed
Covidien (Medtronic) MDL 3029, D. Mass., Judge Patti B. Saris 2,453 / 2,459 Actively litigating; $88M plaintiff verdict August 2026, no punitive damages
Atrium (Getinge) MDL 2753, D.N.H., Judge Landya B. McCafferty 127 / 3,592 Qualified settlement fund approved October 2024; docket largely wound down

Read the pending-versus-filed column carefully. Atrium has resolved roughly 96% of the claims ever filed against it, which is what a completed programme looks like. Bard has resolved comparatively few despite having a framework, and Covidien has barely resolved any. Those three positions imply very different timelines for a claimant today.

Who May Qualify for Hernia Mesh Settlement Amounts

Eligibility turns on identifying the device and documenting a complication attributable to it rather than to the surgery generally.

Common Screening Factors

  • A hernia repair using surgical mesh from Bard, Covidien or Atrium
  • A documented complication — infection, migration, contraction, adhesion, bowel obstruction, perforation or recurrence
  • Revision or explant surgery, which is the clearest indicator of a serious claim
  • Implant records identifying the manufacturer, product and ideally the lot number
  • Ongoing pain or functional impairment attributable to the mesh
  • Claims brought by a personal representative where the patient has died

Factors Requiring Closer Review

  • Devices from manufacturers outside the three MDLs
  • Complications with no revision surgery, which are valued very differently
  • Implant records that do not identify the device
  • Recurrence attributable to surgical technique rather than the product
  • State limitation periods, which usually run from discovery of the complication

For a device litigation at the opposite end of the resolution spectrum, see our Bair Hugger settlement amounts research, and for the wider category our medical device lawsuit research.

Factors That Increase or Reduce Hernia Mesh Settlement Amounts

Across all three programmes, the same factors recur — with manufacturer identity sitting above all of them.

Whether revision surgery occurred

Explant or corrective surgery is the clearest single value driver in mesh litigation. Claims without it sit substantially lower under every framework.

Type and severity of complication

Bowel obstruction, perforation, fistula and chronic infection sit well above chronic pain or recurrence alone.

Number of revision procedures

Multiple explant or repair operations compound both the harm and the documented cost, and indicate a more entrenched problem.

Which manufacturer made the device

A Bard claim, a Covidien claim and an Atrium claim face entirely different resolution landscapes. This is not a detail — it is the framing question.

Permanent functional loss

Chronic pain requiring ongoing management, inability to return to physical work, or permanent restriction on activity.

Strength of product identification

The implant record naming manufacturer, product and lot. Without it a claim may not be assignable to any MDL.

Liens can absorb much of a mesh recovery. Explant and revision surgery is expensive and usually paid by Medicare or a private insurer, which then asserts a right to repayment from any settlement. A claimant with a strong case can still see a large share of a gross allocation absorbed before any net payment.

Evidence Supporting Hernia Mesh Settlement Amounts

One document determines whether a claim can proceed at all: the record identifying which device was implanted.

Implant operative report

The original hernia repair record, with the device recorded. This is where product identification usually comes from.

Device sticker or implant log

Hospitals typically record the manufacturer, product name and lot number. Requesting this specifically is more effective than asking for records generally.

Revision or explant records

Operative reports for any surgery to remove, replace or repair the mesh, with findings on migration, adhesion or infection.

Imaging and pathology

Scans documenting migration, contraction, adhesion or recurrence, and pathology on any explanted mesh.

Complication treatment records

Infection management, bowel obstruction admissions, chronic pain treatment and any specialist referrals.

Economic loss records

Medical bills and explanations of benefits, payroll records showing lost earnings, and documentation of ongoing care needs.

Ask for the implant record by name. A general request for medical records often returns clinical notes without the device documentation that a mesh claim depends on.

Hernia mesh settlement amounts evidence checklist — implant records, product identification and revision surgery
The records behind hernia mesh settlement amounts. Product identification is the gating document.

Filing Deadlines for Hernia Mesh Claims

Because complications can appear years after implantation, the discovery rule is what makes most of these claims possible — and it is also what makes the deadline easy to miss.

The clock generally runs from discovery of the complication, not from the implant surgery. Most states apply a discovery rule so the period begins when a claimant knew or should have known the mesh caused the problem — often the date of a revision surgery or a diagnosis attributing the complication to the device. Those periods are typically two to three years, and existing settlement frameworks do not extend them.

What tends to matter

  • The date the complication was discovered or attributed to the mesh
  • Which state’s law governs
  • Whether a revision surgery started the clock
  • Whether the implant records still exist

What does not pause the clock

  • The existence of a settlement framework or fund
  • Waiting for a verdict in another manufacturer’s MDL
  • Ongoing treatment for the complication
  • Not yet knowing which manufacturer made the device
A missed deadline ends a claim regardless of how serious the complication was. Nothing on this page establishes a deadline for any individual, and only a licensed attorney in the relevant state can confirm which period applies.

Take the Hernia Mesh Settlement Calculator Below

The calculator organises what you know about the implant, the complication, any revision surgery and the financial loss, then shows which factors carry the most weight in a hernia mesh claim. It takes a few minutes and asks for no documents.

The result is educational and is not a guaranteed case value or settlement offer.

Before You Start

  • Roughly when the hernia repair was done
  • Whether you know the manufacturer or product name
  • What complication developed, and when
  • Whether revision or explant surgery followed
  • Any permanent restriction or ongoing pain
  • The state where the surgery took place

Answer what you know. You do not need every record or an exact timeline to get started.

Primary Sources for Hernia Mesh Settlement Amounts

Every figure above traces to one of these. Each was checked on Sept. 1, 2026.

JPML pending-actions report

The JPML report dated Sept. 1, 2026 gives all three dockets: Bard MDL 2846 at 23,316 pending of 25,213 filed, Covidien MDL 3029 at 2,453 of 2,459, and Atrium MDL 2753 at 127 of 3,592.

FDA hernia surgical mesh guidance

FDA identifies pain, infection, hernia recurrence, adhesion, obstruction and bleeding as the most common complications of hernia repair, names mesh migration and contraction as mesh-specific risks, and states the literature has consistently shown reduced recurrence with mesh.

The three MDL dockets

The Atrium qualified settlement fund, the Bard settlement framework and the Covidien trial outcomes are recorded on the dockets in New Hampshire, Ohio and Massachusetts respectively. TortAdvisor cites those dockets rather than secondary coverage.

On the Bard settlement figure

No aggregate settlement total has been disclosed by Bard, by Becton Dickinson or by the court. The figure widely repeated online is an analyst estimate derived from company financial disclosures, and TortAdvisor does not present it as a settlement amount.

The Covidien verdict

The $88 million verdict returned in August 2026 is recorded on the District of Massachusetts docket. No punitive damages were awarded, and the verdict is subject to post-trial and appellate proceedings.

Why no per-claim figure is published

None of the three manufacturers has published allocation criteria or a per-claim matrix. TortAdvisor therefore publishes claim profiles describing relative position rather than dollar bands that would have no source.

Frequently Asked Questions About Hernia Mesh Settlement Amounts

What is the average hernia mesh settlement amount?

There is no reliable average. No manufacturer has published allocation criteria or a per-claim matrix, and the three MDLs are at completely different stages. An average across them would describe no actual claimant.

Did Bard settle the hernia mesh cases for $1 billion?

No such figure has been disclosed. A settlement framework covering a large share of Bard claims has been in place since late 2024, but neither the company nor the court has published a total. The billion-dollar figure circulating online is an analyst estimate derived from financial filings.

How many hernia mesh lawsuits are pending?

As of the Sept. 1, 2026 JPML report: 23,316 against Bard in MDL 2846, 2,453 against Covidien in MDL 3029, and 127 against Atrium in MDL 2753.

What was the $88 million verdict?

A jury returned $88 million against Covidien in August 2026, without punitive damages. It is the largest public hernia mesh outcome and remains subject to post-trial and appellate proceedings, so it is not a settlement benchmark.

Does it matter which mesh I had?

More than almost anything else. Bard, Covidien and Atrium claims sit in separate MDLs with separate judges and completely different resolution positions. Identifying the manufacturer is the first step in any hernia mesh claim.

Do I need to have had revision surgery?

Not strictly, but it is the clearest single value driver. Claims involving explant or corrective surgery are treated very differently from claims where the complication was managed without further operation.

What if my records do not identify the mesh?

That is a common obstacle. Ask the hospital specifically for the implant log or device sticker rather than for medical records generally — the manufacturer and lot number are usually recorded separately from the clinical notes.

Is the hernia mesh settlement calculator legally binding?

No. It is an educational tool that organises claim factors into an illustrative range. It is not a case valuation, not an offer, and binds no manufacturer, court or law firm.

Free Educational Settlement Calculator

See Which Factors May Affect a Hernia Mesh Settlement

Answer the questions you can about the implant, the complication, revision surgery, records, expenses and long-term impact. The calculator organizes those inputs into an educational settlement range and highlights the factors that may matter most when a claim is reviewed.

The result is educational and is not a guaranteed case value or settlement offer.

Private CalculatorNo login is required to use the estimator. Free to UseThere is no fee to complete the calculator. Claim-Factor BasedInjury, treatment, records and damages affect the estimate. No ObligationUsing the calculator does not create representation.

Helpful Information to Have Ready

You do not need every record in hand. Answer what you know; these details can make the estimate more useful.

Date of the hernia repairMesh manufacturerComplication typeRevision surgery recordsHospital and surgeonBills & lost earnings

Before you begin: This calculator uses limited user-entered information and TortAdvisor editorial assumptions. It does not determine liability, legal eligibility, filing deadlines, attorney acceptance or compensation. The result is educational and is not a guaranteed case value or settlement offer.
Answer these few questions about the hernia mesh complication Answer what you know. You do not need every record or an exact timeline to get started.


Reading this page is separate from any request to be contacted. The consent boxes on this form are unchecked unless you tick them yourself.

About the Author

Mason Arnao publishes and edits TortAdvisor. He has spent more than 15 years analyzing personal injury and mass tort litigation and writing reports on it, working directly with some of the largest law firms in the mass tort space. That experience is what these guides are built on: he has seen which settlement figures hold up when a claim is actually reviewed and which ones came from a press release, and he writes these pages for the reader who needs to tell the difference.

Every figure here traces to a court order, a government filing or an official settlement programme. For this guide that means the JPML’s monthly pending-actions reports, the Bard, Covidien and Atrium MDL dockets, and FDA guidance on hernia surgical mesh. No projected, estimated or average payout figure is published here at all, and time-sensitive facts — case counts, hearing dates, court rulings — are rechecked against primary sources rather than repeated from other websites. Where the public record supports no figure at all, we say so instead of estimating.

TortAdvisor is a legal research publisher, not a law firm. We do not represent claimants, give legal advice, accept cases or review claims. Our purpose is to help you understand what the public record actually shows before you speak with an attorney of your own choosing. See our editorial policy and our settlement data methodology for how these guides are compiled and corrected.

LEGAL, MEDICAL, ADVERTISING AND SETTLEMENT-ESTIMATE DISCLAIMER: This page and calculator provide general educational information and illustrative estimates. They do not provide legal advice, medical advice, a case valuation, a settlement offer or a guarantee of eligibility, representation, filing, settlement, trial or compensation. Allegations in MDL 2846, MDL 3029 and MDL 2753 remain disputed. Viewing this page, using the calculator, calling or submitting information does not create an attorney-client relationship. Attorney advertising rules, filing deadlines, recoverable damages and legal standards vary by jurisdiction. Do not stop or change any prescribed treatment or post-surgical care based on litigation coverage, and speak first with a qualified healthcare professional. Seek prompt advice from licensed legal and medical professionals regarding your circumstances.

⚡ Free Confidential Case Evaluation

No fee unless you win · Open 24/7 · Completely confidential

Legal Disclaimer:By clicking "Submit My Case Evaluation," I provide my electronic signature and agree that TortAdvisor, operated by Waypoint Software LLC, and the law firms or marketing partners identified in the Partner List may call, text, or email me about my inquiry at the number and email I provide, including through automated technology, artificial or prerecorded voice, and SMS. Consent is not a condition of purchase or legal services. Message and data rates may apply. Reply STOP to opt out of SMS. I agree to the Terms and Privacy Policy.

Mason Arnao

About Mason Arnao

Mason David Arnao Mason David Arnao is an American entrepreneur, software engineer, and business executive based in Stuart, Florida. His career spans more than two decades in technology, automation, and lead generation systems. Arnao began his professional journey in the late 1990s as a computer technician for the National Basketball Association (NBA), where he was responsible for linking scoreboards, officials’ laptops, and stat monitors to broadcast networks. His technical precision and systems knowledge led him to join Professional Hospital Supply as a software engineer. There, he developed applications that improved data flow between medical suppliers and healthcare institutions, solidifying his foundation in enterprise-grade software development. By the early 2000's, Arnao advanced into web and SaaS infrastructure through Website Buddy LLC, a Florida-based development firm focused on building web tools for small businesses and online marketers. The experience refined his understanding of user-driven software and scalable online systems. In 2013, Arnao founded Waypoint Software, LLC, headquartered in Stuart, Florida. As President and Managing Partner, he built the company into a recognized provider of lead generation and real-time lead distribution technology. Waypoint’s software automates the acquisition, validation, and routing of consumer inquiries for marketing firms and data aggregators worldwide. The company serves hundreds of clients and is listed by the Better Business Bureau under “Sales Lead Generation.” Through Waypoint Software, Arnao has become a notable figure in the digital lead industry, combining technical engineering with automation strategy. His focus on system reliability, transparent data flow, and scalable integrations continues to position Waypoint as an industry leader in real-time lead management solutions.